OR WAIT null SECS
February 06, 2024
The addition of another amino acid recognizer as well as improvements in surface chemistry, reagents, and software expand the proteome coverage of Quantum-Si’s Platinum sequencing platform.
February 05, 2024
The CDMOs are joining together to offer end-to-end development and manufacturing services for protein expression systems and viral vectors in Europe.
Novo Holdings has entered into a merger agreement with Catalent and will acquire Catalent in a deal valued at $16.5 billion.
February 04, 2024
NICE has recommended the use of AbbVie's Tepkinly as a treatment option for eligible adults with diffuse large B-cell lymphoma.
February 03, 2024
ProductLife Group has announced its acquisition of Australian company Commercial Eyes.
February 02, 2024
The agency will coordinate intra-regional medicines regulation to strengthen the African regulatory network.
Under a new collaboration, Lonza and Oxford Nanopore aim to commercialize a CGMP-validated test for advanced analysis of mRNA products.
The UK’s IRP increases flexibility and will help speed up product approvals and patient access to medicines.
The industry’s M&A activity is on the up and expected to continue to rise in 2024.
Agilent Technologies and Incyte have signed an agreement to collaborate on the development of companion diagnostics programs.